In Week of Mar 28, 2026, Archean Chemical Industries Ltd (Chemicals - Inorganic) is outperforming Nifty 500 with +26.7% relative strength. Fundamentals: Weak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Mar 14, 2026
What: Targeting 18,000-ton run rate in FY27 with expansion to 25,000 tons thereafter to drive derivatives growth
Impact: +₹500 Cr revenue
“We will be north of 18,000 tons next year. Right now the goal is to get to a run rate of between 18 and 25,000 at which stage we obviously have to do some expansion work”
What: Plant scale trials commencing soon with meaningful contributions expected in H2 FY27
Impact: +₹200 Cr revenue
“Pilot stage trials for SOP are complete, and plant scale trials are expected to commence soon, with meaningful contributions anticipated in the latter half of FY '27”
What: Return to 1M+ tonne quarterly run rate with stable pricing driving 29% revenue growth
Impact: +₹300 Cr revenue
“During the quarter we sold approximately 1.1 million tonnes of salt, reverting back to our quarterly run rate of more than a million tonnes”
Earnings deceleration risks from management commentary
Trigger: Continued operational disruptions
Impact: -200 bps margin impact
Management view: Our performance remained constrained by operational challenges and disruptions. These did continue to improve.
Monitor: Bromine production volumes
Trigger: Continued bromine price increases
Impact: -300 bps margin impact
Management view: Increasing bromine prices have also put pressure on margins in the derivatives segment
Monitor: Derivatives segment margins
Key quotes from recent conference calls
“We have launched several improvement projects which we expect will help us get back to steady state in Q4 and then we'll further try to scale up operations in the coming quarters. — Management”
“EBITDA margin stood at nearly 27% for the quarter. Increase in expenses were largely due to increase in logistics cost, new employees and other overhead costs from the new units. — Natarajan Ramamurthy, CFO”
“We have a strong demand visibility and our long term contracts. Our customers continue to be in good shape so we continue to expect to scale this business up with some seasonal uptick in Q4 and continuing kind of expansion of operations as well. — Management”
“We will be north of 18,000 tons next year. Right now the goal is to get to a run rate of between 18 and 25,000 at which stage we obviously have to do some expansion work and we're hoping that the Derivatives bromine business will also start scaling up meaningfully at that stage. — Management”
Forward-looking targets from management for FY27
Key Milestones
• 18,000-ton bromine run rate in FY27
• SOP commercial contribution in H2 FY27
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +5% | -3% | Stable |
| PAT (Net Profit) | -50% | -5% | Stable |
| OPM | 21.0% | -1200 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 14, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Archean Chemical Industries Ltd's latest quarterly results (Dec 2025) show
Archean Chemical Industries Ltd's profit is declining with an stable trend.
Archean Chemical Industries Ltd's revenue growth trend is stable.
Archean Chemical Industries Ltd's operating margin is volatile.
Archean Chemical Industries Ltd's long-term compounding rates
Archean Chemical Industries Ltd's earnings growth is stable with negative momentum on a sequential basis.
Archean Chemical Industries Ltd's trailing twelve month (TTM) performance
Archean Chemical Industries Ltd appears significantly overvalued based on our fair value analysis.
Archean Chemical Industries Ltd's current PE ratio is 51.3x.
Archean Chemical Industries Ltd's current PE is 51.3x.
Archean Chemical Industries Ltd's price-to-book ratio is 4.0x.
Archean Chemical Industries Ltd is rated Weak with a fundamental score of 31.9/100. This score is calculated from objective financial metrics
Archean Chemical Industries Ltd has a debt-to-equity ratio of N/A.
Archean Chemical Industries Ltd's return ratios over recent years
Archean Chemical Industries Ltd's operating cash flow is positive (FY2025).
Archean Chemical Industries Ltd's current dividend yield is 0.49%.
Archean Chemical Industries Ltd's shareholding pattern (Dec 2025)
Archean Chemical Industries Ltd's promoter holding has decreased recently.
Archean Chemical Industries Ltd has been outperforming Nifty 500 for 3 consecutive weeks, indicating early-stage outperformance.
Archean Chemical Industries Ltd is an established outperformer with 3 weeks of consecutive Nifty 500 outperformance.
Archean Chemical Industries Ltd has 3 key growth catalysts identified from recent earnings analysis
Archean Chemical Industries Ltd has 2 key risks worth monitoring
In Q3 FY26, Archean Chemical Industries Ltd's management highlighted
Archean Chemical Industries Ltd's management has provided the following forward guidance for FY27
Based on quantitative research signals, here is why Archean Chemical Industries Ltd may be worth studying
Archean Chemical Industries Ltd investment thesis summary:
Archean Chemical Industries Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
